Literature DB >> 17700259

Cell cycle and apoptosis alteration of human hepatocarcinoma cells by subclinical-dose 12C6+-beam irradiation.

Bing Liu1, Hong Zhang, Yi Xie, Jifang Hao, Xin Duan, Qingming Zhou, Rong Qiu, Guangming Zhou.   

Abstract

OBJECTIVE: The purpose of this study is to investigate the effect of subclinical-dose C-beam irradiation on cell cycle and cell apoptosis in hepatocarcinoma cells.
MATERIALS AND METHODS: The HepG2 cells were exposed to 0-2.0 Gy of either the C beam or a gamma-ray. Cell survival was detected by clonogenic assay. Cell cycle was determined by flow-cytometry analysis. The apoptosis was monitored by fluorescence microscope with DAPI staining. p53 and p21 expression were detected by Western blot.
RESULTS: The G0/G1 cells in the irradiated groups were significantly more than those in the control (P<0.05). The C-ion irradiation had a greater effect on the cell cycle of HepG2 cells (including promoting G1-phase and G2-phase arrest) than gamma-ray irradiation. The apoptotic cells induced by C beam were significantly more numerous than those induced by gamma-ray (P<0.05). The carbon ions had a stronger effect on p53 and p21 expression than the gamma-ray irradiation. The survival fractions for cells irradiated by C beam were significantly smaller than those irradiated by gamma-ray (P<0.05).
CONCLUSION: The subclinical-dose C-beam irradiation significantly suppresses HepG2 cells through cell-cycle arrests and cell apoptosis in contrast to same-dose gamma-ray irradiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700259     DOI: 10.1097/MEG.0b013e328220ebeb

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  1 in total

1.  Survivin expressions in human hepatoma HepG2 cells exposed to ionizing radiation of different LET.

Authors:  Xiao-Dong Jin; Li Gong; Chuan-Ling Guo; Ji-Fang Hao; Wei Wei; Zhong-Ying Dai; Qiang Li
Journal:  Radiat Environ Biophys       Date:  2008-03-14       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.